checkAd

    DGAP-Adhoc  933  0 Kommentare Bayer Aktiengesellschaft: Bayer Board of Management plans to focus entirely on Life Science businesses


    Bayer Aktiengesellschaft / Key word(s): Strategic Company Decision

    18.09.2014 08:51

    Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
    by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    ---------------------------------------------------------------------------

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Bayer AG!
    Short
    28,91€
    Basispreis
    0,41
    Ask
    × 14,99
    Hebel
    Long
    25,11€
    Basispreis
    0,19
    Ask
    × 14,18
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Leverkusen, September 18, 2014

    The Board of Management of Bayer AG plans to focus the Bayer Group entirely
    on the Life Science businesses - HealthCare and CropScience - and float
    MaterialScience on the stock market as a separate company. In this way
    Bayer would position itself as a world-leading company in the field of
    human, animal and plant health. The plans remain subject to the approval of
    the Supervisory Board.

    The Board of Management decided this on September 2, 2014. The Supervisory
    Board of Bayer AG will discuss the plans at its meeting today, Thursday. It
    is planned to release further information when the Supervisory Board has
    reached its decision.

    Contact:
    Peter Dahlhoff, Bayer AG, Investor Relations, Phone: 0214-30-33022, e-mail:
    peter.dahlhoff@bayer.com, Fax: +49-214-30-96-33022


    ---------------------------------------------------------------------------

    Information and Explaination of the Issuer to this News:

    Forward-Looking Statements

    This Ad-hoc Statement may contain forward-looking statements based on
    current assumptions and forecasts made by Bayer Group or subgroup
    management. Various known and unknown risks, uncertainties and other
    factors could lead to material differences between the actual future
    results, financial situation, development or performance of the company and
    the estimates given here. These factors include those discussed in Bayer's
    public reports which are available on the Bayer website at www.bayer.com.
    The company assumes no liability whatsoever to update these forward-looking
    statements or to conform them to future events or developments.

    18.09.2014 The DGAP Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Media archive at www.dgap-medientreff.de and www.dgap.de

    ---------------------------------------------------------------------------

    Language: English
    Company: Bayer Aktiengesellschaft
    Kaiser-Wilhelm-Allee 1
    51373 Leverkusen
    Germany
    Phone: +49 (0)214 30-81 013
    Fax: +49 (0)21430-9681013
    E-mail:
    Internet: www.bayer.com
    ISIN: DE000BAY0017
    WKN: BAY001
    Indices: DAX, EURO STOXX 50, Stoxx 50
    Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
    Standard), Hamburg, Hannover, München, Stuttgart; Terminbörse
    EUREX; Madrid

    End of Announcement DGAP News-Service

    ---------------------------------------------------------------------------



    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-Adhoc Bayer Aktiengesellschaft: Bayer Board of Management plans to focus entirely on Life Science businesses Bayer Aktiengesellschaft / Key word(s): Strategic Company Decision 18.09.2014 08:51 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content …

    Schreibe Deinen Kommentar

    Disclaimer